Biotechnology | Diagnostics | Disease | Genomics | NIH | Therapeutics
Draft sequence of the gorilla genome was published
On Mar. 8, 2012, an international team led by researchers at the Wellcome Trust Sanger Institute announced they…
OHSU-led consortium awarded $21 million grant to study alcoholism, stress
On Mar. 8, 2012, the National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded a five-year, $21 million…
Duke Cancer Institute opened the Duke Cancer Center, a new 7-floor building
On Feb. 27, 2012, the Duke Cancer Institute opened a new 267,000-square-foot, $235 million Cancer Center that included…
Mice bred to more closely resemble a genetic variation in humans help target an annual outbreak: the flu
On Feb. 21, 2012, as part of a national collaboration, Oregon Health & Science University researchers were studying…
Biotechnology | Disease | FDA | Therapeutics
The FDA approved Korlym for patients with endogenous Cushing’s syndrome
On Feb. 17, 2012, the FDA announced Korlym (mifepristone) was approved to control high blood sugar levels (hyperglycemia)…
The FDA approved Gleevec for Five Rare, Life-Threatening Disorders
On Jan. 31, 2012, the U.S. Food and Drug Administration (FDA) granted Gleevec (imatinib) regular approval for use…
The FDA approved KALYDECO (ivacaftor) a University of Washington-tested drug to treat the genetic mechanism of cystic fibrosis
On Jan. 31, 2012, the FDA approved a KALYDECO (ivacaftor), University of Washington-tested drug to treat the genetic…
Biotechnology | FDA | Oncology | Therapeutics
The U.S. FDA approved Erivedge (vismodegib) capsule, the first medicine for adults with advanced basal cell carcinoma
On Jan. 30, 2012, the U.S. Food and Drug Administration (FDA) approved Genentech’s Erivedge (vismodegib) capsule, the first…
The UC San Diego Health System acquired the Nevada Cancer Institute
On Jan. 23, 2012, UC San Diego Health System announced it had received approval to acquire the Nevada…
Rock and Roll Hall of Fame inductee Alice Cooper played a benefit concert at OMRF
On Jun. 24, 2012, Rock and Roll Hall of Fame inductee Alice Cooper helped raise $675,500 for the…
Renowned biochemist Michael A Marletta became president and CEO of The Scripps Research Institute
On Jan 1, 2012, renowned biochemist Michael A. Marletta became president and CEO of The Scripps Research Institute…
Alan Aderem, PhD, became president of Seattle BioMed – only the second in its more than 35-year history
On Jan. 1, 2012 Alan Aderem, Ph.D., became president of Seattle BioMed, now known as Center for Infectious…
Biotechnology | Diagnostics | Disease | NIH | Non-Profit Research | Oncology | Therapeutics | Veterinary
The UC Davis Comprehensive Cancer Center received NCI designation
In 2012, The UC Davis Comprehensive Cancer Center received NCI comprehensive cancer designation. The center is a matrix…
CALIBR, the California Institute for Biomedical Research, was founded
In 2012, CALIBR, the California Institute for Biomedical Research (Calibr), was launched as a nonprofit translational research institute…
Smilow Cancer Hospital and Yale Cancer Center opened 8 Smilow Cancer Care Centers in Connecticut
In 2012, Smilow Cancer Hospital and Yale Cancer Center opened 8 Smilow Cancer Care Centers in Connecticut. Today,…
Samantha Lewis at OSU won the Society for Molecular Biology and Evolution Undergraduate Diversity Mentoring Award
In 2012, Samantha Lewis, a senior in the Oregon State University College of Science, won the Society for…
The Basser Center for BRCA was established at Penn Medicine’s Abramson Cancer Center
In 2012, the Basser Center for BRCA was established at Penn Medicine’s Abramson Cancer Center to establish a…
Karmanos researcher Patricia LoRusso appointed co-leader of the Stand Up To Cancer Dream Team
On Dec. 14, 2011, Patricia M. LoRusso, D.O., of the Barbara Ann Karmanos Cancer Institute in Detroit, Michigan;…
Washington University’s Genome Institute received $114 million grant
On Dec. 6, 2011, Washington University’s Genome Institute received a four-year $114 million grant from the National Human…
The CDC activated the Emergency Operations Center to support the global polio eradication effort
On Dec. 2, 2011, the U.S. Centers for Disease Control and Prevention (CDC) Director Thomas R. Frieden, MD,…
MUSC dedicated new bioengineering and drug discovery hubs
On Oct. 24, 2011, the Medical University of South Carolina (MUSC) officially dedicated the James E. Clyburn Research…
The OHSU/OSU Collaborative Life Sciences Building broke ground
On Oct. 13, 2011, the OHSU/OSU Collaborative Life Sciences Building (CLSB) broke ground on the new $295 million…
The CDC responded to a multi-state outbreak of listeriosis
On Sept. 30, 2011, the U.S. Centers for Disease Control and Prevention (CDC) responded to a multi-state outbreak…
Mayo Clinic announced plans to open a medical school in Scottsdale, Arizona
On Sept. 27, 2011, the Mayo Clinic announced a $120 million plan to open its first medical school…
The Monroe Cancer Center opened
On Sept. 2, 2011, the Monroe Cancer Center opened as a joint venture between Karmanos Cancer Institute, Mercy…
Stanford/Packard scientists found new uses for existing drugs by mining gene-activity data banks
On Aug. 17, 2011, researchers at the Stanford University School of Medicine announced they had paired up medicines…
Genentech drug Zelboraf (vemurafenib) was approved
On Aug. 16, 2011, the U.S. Food and Drug Administration (FDA) approved vemurafenib tablets (Zelboraf, Hoffmann-LaRoche Inc.) for…
Genomeon was established under the laws of the Commonwealth of Virginia
On Aug. 11, 2011, Genomeon was established under the laws of the Commonwealth of Virginia by Dr. Harold…
Disease | Life Science History | Medicine | Non-Profit Research | Oncology | Radiology | Therapeutics
Siteman Cancer Center performed its 5,000th bone marrow transplant
On Aug. 9, 2011, the Siteman Cancer Center announced that it had performed its 5,000th bone marrow transplant,…
The Maine Institute for Human Genetics and Health discontinued operations
On Jul. 17, 2011, the Maine Institute for Human Genetics and Health announced that it would cease operations…